Filter by

Keywords

Format

e-posters

Find in this catalogue all the PCR Valves e-Course selected abstracts and posters.

Valve20LBT-POS010
Temporary implantation of the CroiValve Duo tricuspid coaptation valve
SIEVERT H.(1), QUINN M.(2), SIEVERT K.(1), SHABURISHVILI T.(3), SHABURISHVILI N.(3)
(1) CVC Rhein Main, Frankfurt GERMANY
(2) St Vincent's University Hospital, Dublin IRELAND
(3) Ilia State University, Tbilisi GEORGIA

+

Valve20LBT-POS009
Matched comparison of haemodynamics and early outcomes with two alternative balloon-expandable THV
AMAT-SANTOS I. J.(1), DELGADO-ARANA J. R.(1), DE MARCO F.(2), TRANI C.(3), MARTíN P.(4), NOMBELA-FRANCO L.(5), INFUSINO F.(6), ANCONA M.(7), MORENO R.(8), GORDILLO-MONGE X.(5)
(1) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(2) Policlinico san donato, Metropolitan City of Milan ITALY
(3) Policlinico Universitario “Agostino Gemelli”, Metropolitan City of Rome ITALY
(4) Hospital Doctor Negrín, Las Palmas de Gran Canaria SPAIN
(5) Hospital Clínico San Carlos, Madrid SPAIN
(6) Policlinico Gemelli, Metropolitan City of Rome ITALY
(7) San Raffaele Hospital, Metropolitan City of Milan ITALY
(8) Hospital La Paz, Madrid SPAIN

+

Valve20A-POS78
Transcatheter aortic valve commissure alignment with a self-expanding valve: a pilot study
TAGLIARI A. P.(1), VICENTINI L.(1), ZIMMERMANN J. M.(2), FERRARI E.(1), HAAGER P. K.(1), JöRG L.(1), MAISANO F.(1), TARAMASSO M.(1)
(1) University Hospital of Zürich, Zürich SWITZERLAND
(2) ETH Zürich, Zürich SWITZERLAND

+

Valve20A-POS77
Accurate commissural alignment during ACURATE neo TAVR procedure: proof of concept
REDONDO DIÉGUEZ A.(1), VALENCIA SERRANO F.(2), SANTOS MARTíNEZ S.(1), DELGADO ARANA J. R.(1), BARRERO A.(1), SERRADOR A.(1), GUTIERREZ H.(1), RODRIGUEZ GABELLA T.(1), SANCHEZ LITE I.(1), SEVILLA T.(1), REVILLA A.(1), SAN ROMáN J. A.(1), AMAT-SANTOS I. J.(1)
(1) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(2) Torrecárdenas University Hospital, Almería SPAIN

+

Valve20A-POS76
A new far-UVC based system for germ-free cathlabs: Initus-V
OLCAY A.(1), BAKI ALBAYRAK S.(1), FARUK AKTURK I.(2), CENGIZ AKBULBUL M.(3), YOLAY O.(4), IKITIMUR H.(5), YETIM S.(3), CETIN BAYER M.(6)
(1) Istanbul Aydin Üniversitesi, Istanbul TURKEY
(2) Bakirköy Sadi Konuk Education and Research Hospital, Istanbul TURKEY
(3) InnowayRG Inc, Istanbul TURKEY
(4) Bezmialem Vakif University, Technology Transfer Office, Istanbul TURKEY
(5) Biruni Üniversitesi Tip Fakültesi, Istanbul TURKEY
(6) Vestel Home Appliances Research and Development Department, Istanbul TURKEY

+

Valve20A-POS75
Balloon mitral valvotomy using a novel over-the-wire technique in rheumatic mitral stenosis patients with difficult anatomies or failed standard techniques
JOSE ERUNGAREN J.(1), GEORGE P.(1)
(1) Christian Medical College, Tamil Nadu INDIA

+

Valve20A-POS74
Optimal sizing and implant of the Portico valve: OpTech results, a substudy of the Portico I trial
TARAMASSO M. (1), MAISANO F. (1), WORTHLEY S. (2), RODéS-CABAU J. (3), SøNDERGAARD L. (4)
(1) Universitätsspital Zürich, Zürich SWITZERLAND
(2) Royal Adelaide Hospital, SA AUSTRALIA
(3) University of Laval, QC CANADA
(4) Rigshospitalet, Copenhagen Municipality DENMARK

+

Valve20A-POS73
Does prosthesis geometry play a role in the development of leaflet thrombosis following TAVI?
RASHID H. (1), CAMERON J. (1), NASIS A. (1), GOOLEY R. (1)
(1) Monash Medical Centre, VIC AUSTRALIA

+

Valve20A-POS72
Transcarotid approach for TAVR - First results of an alternative access
ESCHENBACH L. K. (1), BAUER S. (1), BAUERNSCHMITT R. (1), GUZMAN CERDA J. (1), VON HODENBERG E. (1), SODIAN R. (1)
(1) MediClin Herzzentrum Lahr/Baden, Lahr GERMANY

+

Valve20A-POS71
Incidence, predictors and outcome of PVL after TAVI
LI Y. J. (1), HAGAR A. (1), CHEN M. (1)
(1) West China Hospital, Sichuan University Community Health Service Center, Sichuan CHINA

+

Valve20A-POS70
TAVR: valves, implantation and procedure - Can we predict conduction disturbances?
ALVES PINTO R. (1), MARTINS CARVALHO M. (1), PROENçA T. (1), TORRES S. (1), COSTA C. (1), PESTANA G. (1), LEBREIRO A. (1), ADãO L. (1), SILVA J. C. (1), MACEDO F. (1)
(1) Centro Hospitalar Universitário São João, Porto PORTUGAL

+

Valve20A-POS69
Validation of non-invasive pressure-volume contractility indices in severe AS
ALDALATI O. (1), ESKANDARI M. (1), DWORAKOWSKI R. (1), CABACA A. R. (1), MARTIN K. (1), BYRNE J. (1), MONAGHAN M. (1), WENDLER O. (1), SHAH A. (1), MACCARTHY P. (1)
(1) King's College Hospital, London UNITED KINGDOM

+

Valve20A-POS68
Restoring tricuspid valve function with a simple TTVR solution
HILDICK-SMITH D. (1)
(1) Royal Sussex County Hospital, Brighton UNITED KINGDOM

+

Valve20A-POS67
TAVI in younger but high-risk patient population: single-centre experience
RUSSO M. (1), CAMMARDELLA A. G. (1), RANOCCHI F. (1), LIO A. (1), SAITTO G. (1), NICOLò F. (1), PERGOLINI A. (1), POLIZZI V. (1), MUSUMECI F. (1)
(1) Azienda Ospedaliera San Camillo Forlanini, Metropolitan City of Rome ITALY

+

Valve20A-POS66
Hybrid use of Angio-Seal and ProGlide for transfemoral TAVR
ÇAKAL B. (1), BOZTOSUN B. (1)
(1) Medipol Mega Üniversite Hastanesi, ?stanbul TURKEY

+

Valve20A-POS65
A daycase TAVI programme for patients with a cardiac pacemaker
WILLIAMS P. (1), VIJAYAN S. (1), MCCALMONT G. (1), MUIR D. (1)
(1) James Cook hospital, Middlesbrough UNITED KINGDOM

+

Valve20A-POS64
TR predicts outcome in patients undergoing percutaneous treatment of MR
BRUNNER S. (1), STAEMPFLI S. F. (1), DE BOECK B. W. (1), WOLFRUM M. (1), TOGGWEILER S. (1)
(1) Luzerner Kantonsspital, Lucerne SWITZERLAND

+

Valve20A-POS63
Comparison of self-expandable and balloon-expandable valves in TAVI: 12 years of single-centre experience
SANTOS SILVA G. (1), SILVA M. (1), CAEIRO D. (1), QUEIRóS P. (1), GONçALVES TEIXEIRA P. (1), FERREIRA D. (1), BRANDãO M. (1), RODRIGUES A. (1), BRAGA P. (1)
(1) Centro Hospitalar Gaia/Espinho - Unidade 1, Vila Nova de Gaia PORTUGAL

+

Valve20A-POS62
Time course of new conduction disturbances following TAVI and its prognostic value
RIBEIRO DA SILVA M. (1), RODRIGUES A. (1), GUERREIRO C. (1), MANUEL A. M. (1), SANTOS SILVA G. (1), TEIXEIRA P. (1), RIBEIRO QUEIRóS P. (1), DIAS A. (1), SOUSA O. (1), BRAGA P. (1)
(1) Centro Hospitalar Vila Nova de Gaia/Espinho - Unidade I, Vila Nova de Gaia PORTUGAL

+

Valve20A-POS61
Minimizing permanent pacemaker implantation following TAVI: value of ascending aorta parameters
HE J. J. (1), OU Y. (1), WU Z. H. (1), LI G. Y. (1), WANG X. (1), ZHOU X. (1), ZHENG M. X. (1), PENG Y. (1), FENG Y. (1), CHEN M. (1)
(1) Department of Cardiology, West China Hospital, Sichuan University, Chengdu CHINA

+

Valve20A-POS60
Early temporal trends assessment of PVL after self-expandable TAVI prostheses
RUSSO G. (1), ZAMBRANO A. (1), BURZOTTA F. (1), PEDICINO D. (1), GRAZIANI F. (1), CANGEMI S. (1), LEONE A. M. (1), AURIGEMMA C. (1), ROMAGNOLI E. (1), TRANI C. (1)
(1) Policlinico Universitario ?Agostino Gemelli?, Metropolitan City of Rome ITALY

+

Valve20A-POS59
MITRA-FR vs. COAPT selection criteria: applicability to real-life patients
GAMBó E. (1), PéREZ A. (1), PEIRó A. (1), ALONSO-VENTURA V. (1), LASALA M. (1), PORTOLéS A. (1), AURED M. C. (1), FERRER-GRACIA M. C. (1), ORTAS NADAL M. D. R. (1)
(1) Hospital Universitario Miguel Servet, Zaragoza SPAIN

+

Valve20A-POS58
Impact of effective regurgitant orifice area on long-term outcome of secondary MR transcatheter repair
KARAM N. (1), ORBAN M. (2), KALBACHER D. (3), BUTTER C. (4), PRAZ F. (5), LUBOS E. (3), PETRESCU A. (6), ILIADIS C. (7), WINDECKER S. (5), LURZ P. (8), VON BARDELEBEN S. (6), HAUSLEITER J. (2)
(1) Hôpital européen Georges Pompidou AP-HP, Paris FRANCE
(2) Großhadern (Klinik), Munich GERMANY
(3) University Medical Center Hamburg-Eppendorf, Hamburg GERMANY
(4) Brandenburgklinik Berlin-Brandenburg, Bernau bei Berlin GERMANY
(5) University of Bern, Bern SWITZERLAND
(6) Mainz University, Mainz GERMANY
(7) Universität zu Köln, Cologne GERMANY
(8) Leipzig University, Leipzig GERMANY

+

Valve20A-POS57
PASCAL mitral valve repair system vs. MitraClip: comparison of transcatheter edge-to-edge strategies in severely degenerative MR
GERçEK M. (1), RODER F. (1), RUDOLPH V. (1), RUDOLPH V. (1), FRIEDRICHS K. (1)
(1) Herz- und Diabeteszentrum NRW, Bad Oeynhausen GERMANY

+

Valve20A-POS56
Reduction of paravalvular regurgitation with the novel balloon-expandable SAPIEN 3 Ultra TAVR prosthesis
TAMM A. R. (1), HELL M. M. (1), GEYER M. (1), SEIDL M. (1), DA ROCHA E SILVA J. G. (1), KREIDEL F. (1), KORNBERGER A. (1), BEIRAS-FERNANDEZ A. (1), VON BARDELEBEN R. S. (1), MüNZEL T. (1)
(1) University Medical Center Mainz, Mainz GERMANY

+

Valve20A-POS55
Real-world experience with MyVal balloon expandable THV
JOSE ERUNGAREN J. (1), GEORGE P. (1), RAJANALA P. K. (1)
(1) Christian Medical College, Tamil Nadu INDIA

+

Valve20A-POS54
Prognostic and symptomatic significance of acute reduction of MR after transcatheter edge-to-edge therapy in a large monocentric analysis with long-term follow-up
GEYER M. (1), KELLER K. (1), TAMM A. (1), BORN S. (1), BACHMANN K. (1), RUF T. (1), KREIDEL F. (1), PETRESCU A. (1), HELL M. (1), BEIRAS-FERNANDEZ A. (1), SCHULZ E. (1), MüNZEL T. (1), VON BARDELEBEN R. S. (1)
(1) Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz GERMANY

+

Valve20A-POS53
Short-term clinical outcomes of TTVR with the third-generation MitraClip XTR system
RUF T. F. (1), HAHN R. (2), KREIDEL F. (1), BEIRAS-FERNANDEZ A. (3), HELL M. (1), SCHMITZ V. (1), GERDES P. (1), PETRESCU A. (1), DA ROCHA E SILVA J. G. (1), VOSSELER M. (1), GEYER M. (1), TAMM A. (1), MüNZEL T. (1), VON BARDELEBEN R. S. (1)
(1) Center of Cardiology, Heart Valve Center, University Medical Center Mainz, Johannnes Gutenberg Universität Mainz, Mainz GERMANY
(2) Cardiology Department, New York-Presbyterian Hospital - Columbia University Medical Center, NY UNITED STATES
(3) Department of Heart and Vascular Surgery, Heart Valve Center, University Medical Center Mainz, Johannnes Gutenberg Universität Mainz, Mainz GERMANY

+

Valve20A-POS52
A single-centre real-world experience using the MyVal balloon-expandable THV
IELASI A. (1), BUONO A. (1), MEDDA M. (1), CASILLI F. (1), BANDE M. (1), PELLICANO M. (1), MESSINA F. (1), GLUABER M. (1), DONATELLI F. (1), TESPILI M. (1)
(1) Istituto Clinico Sant'Ambrogio, Metropolitan City of Milan ITALY

+

Valve20A-POS51
Single-centre experience with SAPIEN 3 Ultra balloon-expandable TAV: early outcomes
CAMMARDELLA A. G. (1), RUSSO M. (1), NICOLò F. (1), PERGOLINI A. (1), LIO A. (1), POLIZZI V. (1), RANOCCHI F. (1), MUSUMECI F. (1)
(1) Azienda Ospedaliera San Camillo Forlanini, Metropolitan City of Rome ITALY

+

Valve20A-POS50
Concomitant TV regurgitation and its secondary reduction after TMV edge-to-edge repair: predictors for long-term survival and symptomatic benefit
GEYER M. (1), KELLER K. (1), TAMM A. (1), RUF T. (1), KREIDEL F. (1), PETRESCU A. (1), HELL M. (1), BORN S. (1), BACHMANN K. (1), BEIRAS-FERNANDEZ A. (1), SCHULZ E. (1), MüNZEL T. (1), VON BARDELEBEN R. S. (1)
(1) Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz GERMANY

+

Valve20A-POS49
Left atrial and LAA remodeling after TAVR
XIONG T. Y. (1), FENG Y. (1), CHEN M. (1)
(1) West China Hospital, Sichuan University, Chengdu CHINA

+

Valve20A-POS48
Quantitative videodensitometric assessment of angiographic paravalvular regurgitation after aortic valve implantation of three balloon expandable valves
KAWASHIMA H. (1), WANG R. (1), ONO M. (1), HARA H. (1), GAO C. (1), ROSSEEL L. (1), MYLOTTE D. (1), ONUMA Y. (1), SERRUYS P. (1), SOLIMAN O. (1)
(1) National University of Ireland Galway, Galway IRELAND

+

Valve20A-POS47
A concept of lean TAVI to minimise utilisation of hospital resources
TOGGWEILER S. (1), TOGGWEILER S. (2), ODERMATT B. (2), MOCCETTI F. (2), WOLFRUM M. (2), KOBZA R. (2)
(1) ,
(2) Luzerner Kantonsspital, Lucerne SWITZERLAND

+

Valve20A-POS45
Hemodynamic comparison of TAVR with the SAPIEN 3 Ultra vs. SAPIEN 3: the HomoSAPIEN registry
MORIYAMA N. (1)
(1) Shonan Kamakura General Hospital, Kanagawa JAPAN

+

Valve20A-POS44
Safety and efficacy of TAVR in patients with severe, symptomatic AS aged 90 years or older
ZADROZNY M. (1), HAINZER N. (1), MEHILLI J. (1), GSCHWENDTNER S. (1), STEFFEN J. (1), THEISS H. (1), SADONI S. (1), MASSBERG S. (1), HAUSLEITER J. (1), DESEIVE S. (1)
(1) LMU Klinikum, Munich GERMANY

+

Valve20A-POS43
Predictors and prognostic impact of early EF recovery in patients with severe AS and reduced EF after TAVI
SILVA C. (1), BRIZIDO C. (1), TRABULO M. (1), FREITAS P. (1), RIBEIRAS R. (1), TELES R. (1), ANDRADE M. J. (1), BRITO J. (1), NOLASCO T. (1), MENDES M. (1)
(1) Hospital Santa Cruz, Carnaxide PORTUGAL

+

Valve20A-POS42
Quantitative angiographic assessment by videodensitometry of aortic valve regurgitation in self-expanding valves: a retrospective analysis
WANG R. (1), KAWASHIMA H. (2), GAO C. (1), ROSSEEL L. (2), MYLOTTE D. (2), YANG J. (1), ONUMA Y. (2), SOLIMAN O. (2), SERRUYS P. (2), TAO L. (1)
(1) Xijing Hospital, Shaanxi CHINA
(2) National University of Ireland Galway, Galway IRELAND

+

Valve20A-POS41
TMVI in patients with prior TAVI and mitral annular calcification
DAHLE G. (1), REIN K. A. (1)
(1) Rikshospitalet, Oslo NORWAY

+

Valve20A-POS40
Outcomes of enoxaparin treatment in pregnant women with mechanical heart valve without anti-Xa monitoring
FARHAN H. A. (1), ROOS-HESSELINK J. W. (2), YASEEN I. F. (1)
(1) Baghdad Teaching Hospital, Baghdad IRAQ
(2) Erasmus MC, Rotterdam NETHERLANDS

+

Valve20A-POS39
Optimising TAVI with peri-annular structures in patients with non-calcified native pure AR
OU Y. (1), HE S. (1), YAO Y. (1), WANG X. (1), WEI J. (1), HE S. (1), WEI J. (1), PENG Y. (1), YUAN F. (1), CHEN M. (1)
(1) West China Hospital, Sichuan University, Sichuan CHINA

+

Valve20A-POS38
Semi-quantitative aortic valve tissue characterisation independently predicts paravalvular regurgitation following TAVI
HELL M. (1), MARWAN M. (1), CADET S. (2), ARNOLD M. (1), ACHENBACH S. (1), DEY D. (2)
(1) Department of Cardiology, Friedrich-Alexander University of Erlangen Nürnberg, Germany, Erlangen GERMANY
(2) Biomedical Imaging Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, USA, Los Angeles UNITED STATES

+

Valve20A-POS37
Ineligibility reasons for cerebral embolic protection during TAVR
DU Y. (1), GARCIA S. (1), GöSSL M. (1), CAVALCANTE J. (1), HASHIMOTO G. (1), FUKUI M. (1), LOPES B. (1), SORAJJA P. (1)
(1) Minneapolis Heart Institute - Valve Center, MN UNITED STATES

+

Valve20A-POS36
Patient-specific computer simulation in TAVR with the self-expanding Evolut R valve. The multicentre prospective TAVIguide study
DE JAEGERE P. (1), EL FAQUIR N. (1), DE BACKER O. (2), BOSMANS J. (3), RUDOLPH T. (4), BUZZATTI N. (5), LATIB A. (6), ADAM M. (4), REN B. (1), VAN MIEGHEM N. (1)
(1) Erasmus MC, Rotterdam NETHERLANDS
(2) Rigshospitalet, Copenhagen Municipality DENMARK
(3) UZA, Edegem BELGIUM
(4) University Hospital Cologne, Cologne GERMANY
(5) San Raffaele Hospital, Metropolitan City of Milan ITALY
(6) Montefiore Medical Center Moses Division, NY UNITED STATES

+

Valve20A-POS35
Evolution of right ventricle dysfunction and tricuspid regurgitation after TAVI: a prospective study
LORCA L. (1), AKODAD M. (1), DUFLOS C. (1), AGULLO A. (1), MACIA J. C. (1), DELSENY D. (1), SCHMUTZ L. (2), GANDET T. (1), CAYLA G. (2), LECLERCQ F. (1)
(1) CHU MONTPELLIER, MONTPELLIER FRANCE
(2) CHU NIMES CAREMEAU, NIMES FRANCE

+

Valve20A-POS34
Impact of baseline mitral and/or tricuspid regurgitation in patients with LV dysfunction undergoing TAVI
COBURN J. (1), BRENNAN P. (1), COLLINS P. (1), JEGANATHAN R. (1), JOHNSTON N. (1), OWENS C. (1), SPENCE M. S. (1), MANOHARAN G. (1)
(1) Royal Victoria Hospital, Belfast UNITED KINGDOM

+

Valve20A-POS33
Evaluation of regurgitation after TAVI. Comparisons of angiography, TTE and AR index
FRANZEN C. (1), MICHEL J. (2), FRANGIEH A. (3), MANKERIOUS N. (4), PELLEGRINI C. (3), RHEUDE T. (3), OTT I. (5), JONER M. (3), KASEL A. M. (2)
(1) Technische Universität München, Munich GERMANY
(2) Universitätsspital Zürich, Zürich SWITZERLAND
(3) Deutsches Herzzentrum München, Munich GERMANY
(4) SEGEBERGER KLINIKEN GMBH, Bad Segeberg GERMANY
(5) Helios Klinikum Pforzheim, Pforzheim GERMANY

+

Valve20A-POS32
Different anatomic severity classified on echocardiography evaluating clinical prognosis in patients undergoing TAVR
WEI X. (1), XIN W. (1), CHEN M. (1)
(1) West China Hospital, Sichuan University Community Health Service Center, Sichuan CHINA

+

Valve20A-POS31
Influence factors of mitral regurgitation changes after TAVR
LI Q. (1), LI Q. (2), CHEN M. (2), WEI X. (2), LI Q. (2), OU Y. W. (2), WANG X. (2), LI Q. (2), TANG H. (2), CHEN M. (2)
(1) ,
(2) West China Hospital, Sichuan University, Sichuan CHINA

+

Valve20A-POS30
Transient LV dysfunction peri-aortic valve intervention; invasive pressure-volume loop study
ALDALATI O. (1), DWORAKOWSKI R. (1), CABACA R. (1), MARTIN K. (1), BYRNE J. (1), MONAGHAN M. (1), ESKANDARI M. (1), WENDLER O. (1), SHAH A. (1), MACCARTHY P. (1)
(1) King's College Hospital, London UNITED KINGDOM

+

Loading...